Glucose Health, Inc.
Glucose Health, Inc.
No insider data available
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | - | - | - | 0 | - | - | - | 0 | |||||
Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | |||||
Inventory Net | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Due From Affiliates | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Prepaid Expense Current | 0 | - | - | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | |||||
Other Assets | |||||||||||||||||
Indefinite Lived Intangible Assets Excluding Goodw… | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accounts Payable And Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Interest Payable Current | - | - | - | - | 0 | 0 | - | - | - | - | - | - | |||||
Accrued Liabilities Current | 0 | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | |||||
Notes Payable Related Parties Classified Current | 0 | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | |||||
Notes Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | |||||||||||||||||
Liabilities Current | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Convertible Notes Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Convertible Notes Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Current | |||||||||||||||||
Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Notes Payable Current | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | |||||
Liabilities | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | |||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 6 | 6 | 6 | 6 | 6 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | |||||
Common Stock Shares Subscriptions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | |||||
Retained Earnings Accumulated Deficit | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | |||||
Liabilities And Stockholders Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | |||||||||||||||||
Stockholders Equity | -0 | -0 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | |||||
Cash | - | - | - | - | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | |||||
Accumulated Amortization Of Noncurrent Deferred Fi… | 0 | 0 | 0 | 0 | - | - | - | 0 | 0 | - | - | 0 | |||||
Preferred Stock Shares Authorized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | |||||
Common Stock Shares Issued | 5 | 4 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 1 | |||||
Shares Outstanding | 5 | 4 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 1 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017 | 0.00% | -18.18% | 2.73% | 160.00% | 112.00% | 44.00% | -0.87% | -44.35% | -38.26% | - | - | - |
| 2016 | 144.44% | 406.67% | 322.22% | -33.33% | -66.67% | -71.67% | 40.00% | 10.00% | 12.00% | 204.35% | 132.61% | 128.26% |
| 2015 | 25.00% | -12.50% | 2.50% | -2.44% | 9.76% | -4.88% | 100.00% | 42.86% | -14.29% | -4.44% | 51.11% | 877.78% |
| 2014 | - | - | - | - | - | - | - | - | - | 0.00% | -11.11% | -8.89% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.06 | 0.06 | 0.03 | 0.06 | 0.10 | 0.49 | 0.11 | 0.04 | 0.05 | 0.06 | 0.10 | 0.13 | |||||
| Quick Ratio | 0.06 | 0.06 | 0.03 | 0.06 | 0.09 | 0.46 | 0.01 | 0.01 | 0.03 | 0.01 | 0.01 | 0.02 | |||||
| Working Capital | -426.43K | -449.50K | -523.79K | -495.69K | -373.93K | -217.00K | -403.43K | -388.12K | -362.06K | -330.64K | -332.56K | -280.85K | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -1.06 | -1.06 | -1.04 | -1.07 | -1.12 | -1.96 | -1.13 | -1.04 | -1.06 | -1.06 | -1.11 | -1.16 | |||||
| Interest Coverage TTM | -0.27 | -0.42 | -0.33 | -0.27 | -0.32 | -0.38 | -1.27 | -1.30 | -3.61 | -3.24 | -3.60 | -4.97 | |||||
| Debt Ratio | 17.17 | 17.45 | 28.75 | 15.95 | 9.50 | 2.05 | 8.81 | 26.17 | 18.21 | 17.05 | 9.84 | 7.37 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 2.51 | 0.57 | 9.31 | 12.90 | 9.22 | 2.63 | 0.10 | 0.14 | 0.15 | 0.16 | 0.09 | 0.08 | |||||
| Days Sales Outstanding TTM | 43.17 | 486.45 | 7.11 | 8.67 | 8.36 | 205.08 | 263.28 | 269.14 | 274.58 | - | - | - | |||||
| Receivables Turnover TTM | 8.45 | 0.75 | 51.36 | 42.12 | 43.68 | 1.78 | 1.39 | 1.36 | 1.33 | - | - | - | |||||
Per Share Metrics | |||||||||||||||||
| Free Cash Flow Per Share TTM | -0.00 | 0.01 | -0.00 | -0.01 | -0.02 | -0.07 | -0.04 | -0.06 | -0.07 | -0.05 | -0.13 | -0.20 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 65.39% | 48.16% | 5.97% | 6.12% | 6.29% | 7.20% | 9.89% | 9.29% | -407.37% | -378.28% | -726.83% | -756.70% | |||||
| Operating Profit Margin TTM | -36.82% | -139.40% | -31.29% | -27.66% | -25.60% | -18.46% | -2,375.31% | -3,655.74% | -19,083.85% | -18,825.26% | -20,979.09% | -19,905.66% | |||||
| Net Profit Margin TTM | -106.63% | -411.64% | -124.97% | -131.04% | -108.20% | -70.98% | -4,014.91% | -6,228.09% | -24,139.74% | -24,424.55% | -27,346.34% | -24,439.91% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -70.59% | -77.82% | 7,415.91% | 7,232.14% | 11,285.98% | 10,498.66% | 60.73% | 55.97% | -3.91% | 296.49% | 902.58% | 1,122.77% | |||||
| Net Income Growth (1Y) | -71.02% | 28.62% | 133.95% | 54.26% | -48.97% | -69.20% | -76.40% | -60.25% | -35.53% | -32.82% | -41.49% | -54.12% | |||||
| EPS Growth (1Y) | -79.90% | -10.50% | 75.25% | 8.03% | -62.17% | -76.96% | -85.28% | -86.28% | -82.79% | -83.66% | -79.11% | -79.80% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -10.15 | -1.22 | -0.34 | -0.28 | -0.80 | -4.43 | -0.60 | -0.37 | -0.17 | -0.14 | -0.09 | -0.10 | |||||
| P/B TTM | -2.24 | -0.74 | -0.27 | -0.23 | -0.69 | -4.35 | -0.26 | -0.25 | -0.29 | -0.29 | -0.21 | -0.24 | |||||
| P/S TTM | 10.83 | 5.04 | 0.43 | 0.37 | 0.86 | 3.14 | 24.08 | 22.90 | 40.52 | 34.23 | 25.87 | 24.90 | |||||
| Market Cap | 954.06K | 334.63K | 140.36K | 114.54K | 258.93K | 941.78K | 105.14K | 97.82K | 106.64K | 96.77K | 70.29K | 68.19K | |||||
| Enterprise Value | 1.06M | 443.48K | 248.51K | 167.63K | 315.06K | 1.06M | 256.75K | 202.67K | 191.95K | 172.68K | 125.76K | 94.99K | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -17.25K | 46.29K | -2.19K | -39.26K | -45.16K | -186.92K | -95.24K | -115.78K | -142.06K | -104.72K | -203.79K | -135.35K | |||||
| Net Debt | 105.52K | 108.84K | 108.15K | 53.09K | 56.13K | 114.74K | 151.61K | 104.85K | 85.31K | 75.91K | 55.48K | 26.80K | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Glucose Health, Inc. (GLUC) — SEC Financial Statements & Analysis
Glucose Health, Inc. (GLUC) is a medicinal chemicals & botanical products company, incorporated in DE. Glucose Health, Inc. trades on OTC as: GLUC. Based on its latest SEC filing (Form 10-Q, period ending 2017-09-30), Glucose Health, Inc. reported a -70.59% year-over-year revenue growth, a Gross Profit Margin of 65.39% (TTM), a Debt-to-Equity ratio of -1.06x, a Price-to-Sales (P/S) ratio of 10.83x (TTM), a Price-to-Book (P/B) ratio of -2.24x (TTM), at a market cap of $954.06K. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -70.59%
- Gross Profit Margin TTM
- 65.39%
- Debt To Equity
- -1.06x
- P/S TTM
- 10.83x
- P/B TTM
- -2.24x
- Market Cap
- $954.06K
Data as of 2017-09-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Glucose Health, Inc. in?
Glucose Health, Inc. (GLUC) operates in the Medicinal Chemicals & Botanical Products industry.
What is GLUC's market cap?
Glucose Health, Inc. (GLUC) has a market capitalization of $954.06K as of 2017-09-30.
What exchange does GLUC trade on?
Glucose Health, Inc. (GLUC) trades on the OTC.
Where is Glucose Health, Inc. incorporated?
Glucose Health, Inc. is incorporated in DE.